Hem › Crohns sjukdom › Wisconsin
Kliniska studier för Crohns sjukdom i Wisconsin
7 studier för Crohns sjukdom söker deltagare vid platser i Wisconsin.
Städer i Wisconsin
Officiell studietext (engelska)
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Wisconsin Center for Advanced Research, Milwaukee
RekryterarFas 3
Ålder 18 till 70 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06937099An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Froedtert Hospital and the Medical College of Wisconsin-Site Number: 8400081, Milwaukee
RekryterarFas 3
Ålder 16 till 80 · Alla kön · Uppdaterad 23 sep. 2026 · NCT07184931Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Medical College of Wisconsin, Milwaukee
RekryterarFas 4
Ålder 6 till 17 · Alla kön · Uppdaterad 27 maj 2026 · NCT05781152A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- Medical College of Wisconsin Cancer Center - Froedtert Hospital, Milwaukee
RekryterarFas 3
Ålder 18 till 65 · Alla kön · Uppdaterad 27 maj 2026 · NCT06227910Precise Infliximab Exposure and Pharmacodynamic Control
- Medical College of Wisconsin, Children's of Wisconsin, Milwaukee
RekryterarFas 2/3
Ålder 6 till 22 · Alla kön · Uppdaterad 5 maj 2026 · NCT05660746A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Milwaukee
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 12 mars 2026 · NCT07113522Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
- Brain Inflammation Collaborative, Delafield
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 2 och äldre · Alla kön · Uppdaterad 22 jan. 2026 · NCT04806620Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.